Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • US Supreme Court overturns Roe vs Wade in major blow to abortion rights
    • Boris Johnson’s leadership in fresh crisis after Conservatives lose two by-elections
    • Covid infections rise 20% in England as new Omicron variants spread
    • Ukrainian troops ordered to retreat from Severodonetsk
    • Recession in US and Europe ‘increasingly likely’, warn economists
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • US Supreme Court overturns Roe vs Wade in major blow to abortion rights
    • Stocks snap weekly losing streak on scaled back rate-rise expectations
    • A devastating blow to women’s rights in America
    • The case against Trump: Has the January 6 committee changed minds?
    • Abortion in America — the road to rolling back Roe vs Wade
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Fintechs face reckoning as easy money dries up
    • Rising rates raise prospect of property crash
    • SoftBank’s Masayoshi Son backs Nasdaq listing for Arm despite UK pressure
    • Barclays to buy UK specialist lender Kensington Mortgages
    • Zalando warning sends shares below 2014 listing price before late revival
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Stocks snap weekly losing streak on scaled back rate-rise expectations
    • Live news updates from June 24: US Supreme Court overturns Roe vs Wade, Ukrainian forces to retreat from Severodonetsk
    • Investors yearn for the catharsis of hitting a market bottom
    • Meet Zoltan, the sellside Jules Verne
    • Is it too early for investors to buy the dip?
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • A devastating blow to women’s rights in America
    • Investors yearn for the catharsis of hitting a market bottom
    • Your phone’s notification settings and the meaning of life
    • Crypto enthusiasts are betting the house on creative destruction
    • Lessons for Conservatives from the double by-election blow
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Mikhail Khodorkovsky: ‘Putin has embarked on a route that is going to lead to his demise’
    • Why pay rises for your company’s ‘flight risks’ can backfire
    • Humour in the office matters, but can a boss be funny?
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Inside the secret, often bizarre world that decides what porn you see
    • Writer Vladimir Sorokin: ‘I underestimated the power of Putin’s madness’
    • Abortion in America — the road to rolling back Roe vs Wade
    • She was loved for standing up to China. She may die in jail
    • Your phone’s notification settings and the meaning of life
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Medical science

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 24 June, 2022
    Coronavirus pandemic
    Covid infections rise 20% in England as new Omicron variants spread

    Scotland hit hardest in the UK as cases climb 40% to leave one in 20 people suffering from the disease

  • Friday, 24 June, 2022
    The FT ViewThe editorial board
    Living with Covid-19 requires caution, not complacency

    Governments need to plan now for what could be a tough autumn

  • Friday, 24 June, 2022
    Disease control and prevention
    Monkeypox thought to be mutating faster than anticipated, study finds

    WHO debates raising classification of outbreak as some authorities widen eligibility for vaccines

  • Friday, 24 June, 2022
    Covid-19 vaccines
    Sanofi-GSK Covid vaccine found effective against Omicron

    Pharma companies are hoping to catch up with rivals as they report promising trial results for jab

  • Thursday, 23 June, 2022
    Covid-19 vaccines
    Covid vaccines prevented 20mn deaths globally, study finds

    Mathematical modelling looked at deaths directly and indirectly linked to jabs

  • Thursday, 23 June, 2022
    Coronavirus treatment
    UK prepares to include over-50s in autumn Covid booster campaign

    Javid says he asked officials to revise previous plans that would exclude under-65s

  • Thursday, 23 June, 2022
    Coronavirus pandemic
    Flu epidemic risks sweeping China left vulnerable by zero-Covid fixation

    Xi Jinping orders public health policy to prioritise Covid control over all other diseases

  • Wednesday, 22 June, 2022
    Poliovirus detected in London sewage samples

    UK health agency investigating possibility of community transmission says risk to public ‘extremely low’

  • Wednesday, 22 June, 2022
    Moderna
    Moderna calls for approval of two-strain Covid vaccine booster

    US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases

  • Wednesday, 22 June, 2022
    Covid-19 vaccines
    UK signs £1bn deal with Moderna for new vaccine centre

    Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech

  • Monday, 20 June, 2022
    Uhuru Kenyatta
    President Kenyatta: We need vaccines and investment to tip the scales against malaria

    After years in retreat, the disease is once again on the rise across the continent

  • Monday, 20 June, 2022
    Pfizer Inc
    Pfizer buys stake in French vaccine maker Valneva

    US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme

  • Sunday, 19 June, 2022
    Banks
    Bankers’ beach holidays threatened by market turmoil

    Financiers suffering lacklustre first half performance are poised to cancel summer plans in bid to claw back business

  • Friday, 17 June, 2022
    Chinese politics & policy
    China turns Winter Olympic villages into Covid quarantine camps

    Facilities used to house foreign athletes during February Games converted into isolation centres

  • Friday, 17 June, 2022
    Coronavirus pandemic
    Covid hospital admissions rise in Europe as sub-variants fuel new wave

    Omicron offshoots BA.4 and BA.5 drive increase in infections in Portugal, UK, France and Germany

  • Thursday, 16 June, 2022
    Covid-19 vaccines
    WHO set to back use of Covid variant-specific vaccines as third shot

    Recommendation by health agency advisory group marks shift in thinking of global health authorities

  • Thursday, 16 June, 2022
    Charity launches £80mn programme with US partner to address cancer challenges

    Cancer Research UK will eventually spend £295mn with National Cancer Institute on projects to understand and prevent tumour growth

  • Wednesday, 15 June, 2022
    Covid-19 vaccines
    FDA advisory panel backs Covid-19 vaccines for children under 5

    US prepares to roll out jabs to last age group without access once regulatory approval is received

  • Wednesday, 15 June, 2022
    Scientists use ancient DNA samples to explain Black Death origins

    Genetic and archaeological evidence show plague pandemic began in Kyrgyzstan in 1338

  • Tuesday, 14 June, 2022
    The Big Read
    BioNTech’s second act: can it transform the fight against cancer?

    The German company is ploughing Covid vaccine profits into oncology but its technology is still largely unproven

  • Monday, 13 June, 2022
    US economy
    Gorman defends US economy as markets shudder on recession fears

    Morgan Stanley chief says he is ‘totally relaxed’, pointing to strength of consumer credit

  • Friday, 10 June, 2022
    James Kynge
    The human and economic cost of China’s zero-Covid strategy is mounting

    Beijing’s techno-authoritarian approach to containing the virus is just another iteration of digital dystopia

  • Friday, 10 June, 2022
    Pharmaceuticals sector
    GSK hopes for boost from respiratory virus jab

    Successful trials for RSV vaccine add much-needed lift to the UK drugmaker’s pipeline

  • Friday, 10 June, 2022
    News in-depthDisease control and prevention
    Preventing another Covid-19: Ugandan lab leads hunt for zoonotic diseases

    Drive to identify emerging viruses that pass from animals to humans comes amid fears over spread of monkeypox

  • Thursday, 9 June, 2022
    Coronavirus pandemic
    China’s reopening already faces challenges

    Revolving lockdowns are likely to exact a heavy economic toll in 2022

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In